Literature DB >> 21052896

Indocyanine green angiography findings in initial acute pretreatment Vogt-Koyanagi-Harada disease in Japanese patients.

Masaru Miyanaga1, Tatsushi Kawaguchi, Kazunori Miyata, Shintaro Horie, Manabu Mochizuki, Carl P Herbort.   

Abstract

PURPOSE: Indocyanine green angiography (IA) is a highly sensitive method to evaluate choroidal inflammatory lesions. We present standardized IA findings of initial acute Vogt-Koyanagi-Harada (VKH) disease in Japanese patients before therapeutical intervention.
METHODS: Medical records of patients with VKH disease at Tokyo Medical and Dental University Hospital and Miyata Eye Hospital were retrospectively analyzed. We analyzed six IA signs: choroidal perfusion inhomogeneity, early hyperfluorescent stromal vessels, hypofluorescent dark dots (HDDs), fuzzy or lost pattern of large stromal vessels, disc hyperfluorescence, and diffuse late choroidal hyperfluorescence.
RESULTS: Ten patients from the two hospitals were studied. The most constant findings present in all eyes were early hyperfluorescent stromal vessels, HDDs, and either fuzzy or lost pattern of large stromal vessels. Disc hyperfluorescence was present in 18 eyes. Choroidal perfusion inhomogeneity was seen in six patients, and diffuse late choroidal hyperfluorescence was seen to a certain degree in all eyes.
CONCLUSIONS: Four of the analyzed signs, including early hyperfluorescent stromal vessels, HDDs, fuzzy or lost pattern of large stromal vessels, and disc hyperfluorescence were consistent findings in Japanese VKH patients. Because the primary lesion is situated in the choroid, IA is the method of choice to monitor disease activity in VKH disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21052896     DOI: 10.1007/s10384-010-0853-6

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  17 in total

1.  Indocyanine green angiographic findings in Vogt-Koyanagi-Harada disease.

Authors:  Y Oshima; S Harino; Y Hara; Y Tano
Journal:  Am J Ophthalmol       Date:  1996-07       Impact factor: 5.258

2.  The contribution of indocyanine green angiography to the appraisal and management of Vogt-Koyanagi-Harada disease.

Authors:  N Bouchenaki; C P Herbort
Journal:  Ophthalmology       Date:  2001-01       Impact factor: 12.079

3.  Identification of autoreactive T cells in Vogt-Koyanagi-Harada disease.

Authors:  K Gocho; I Kondo; K Yamaki
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-08       Impact factor: 4.799

4.  Schematic interpretation of indocyanine green angiography in posterior uveitis using a standard angiographic protocol.

Authors:  C P Herbort; P LeHoang; Y Guex-Crosier
Journal:  Ophthalmology       Date:  1998-03       Impact factor: 12.079

5.  Indocyanine green angiography in inflammatory eye disease.

Authors:  L Howe; M Stanford; E Graham; J Marshall
Journal:  Eye (Lond)       Date:  1998       Impact factor: 3.775

6.  Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature.

Authors:  R W Read; G N Holland; N A Rao; K F Tabbara; S Ohno; L Arellanes-Garcia; P Pivetti-Pezzi; H H Tessler; M Usui
Journal:  Am J Ophthalmol       Date:  2001-05       Impact factor: 5.258

7.  T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1*0405-positive and -negative Vogt-Koyanagi-Harada uveitis.

Authors:  Francisco Max Damico; Edecio Cunha-Neto; Anna Carla Goldberg; Leo Kei Iwai; Maria Lucia Marin; Juergen Hammer; Jorge Kalil; Joyce Hisae Yamamoto
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-07       Impact factor: 4.799

8.  Videofunduscopy and videoangiography using the scanning laser ophthalmoscope in Vogt-Koyanagi-Harada syndrome.

Authors:  A A Okada; T Mizusawa; J Sakai; M Usui
Journal:  Br J Ophthalmol       Date:  1998-10       Impact factor: 4.638

9.  Suboptimal therapy controls clinically apparent disease but not subclinical progression of Vogt-Koyanagi-Harada disease.

Authors:  Tatsushi Kawaguchi; Shintaro Horie; Nadia Bouchenaki; Kyoko Ohno-Matsui; Manabu Mochizuki; Carl P Herbort
Journal:  Int Ophthalmol       Date:  2009-01-17       Impact factor: 2.031

10.  Work-up, diagnosis and management of acute Vogt-Koyanagi-Harada disease: a case of acute myopization with granulomatous uveitis.

Authors:  Alessandro Mantovani; Anna Resta; Carl P Herbort; Ahmed Abu El Asrar; Tatsushi Kawaguchi; Manabu Mochizuki; Annabelle A Okada; Narsing A Rao
Journal:  Int Ophthalmol       Date:  2007-05-05       Impact factor: 2.029

View more
  19 in total

1.  Clinical and multimodal imaging characteristics of acute Vogt-Koyanagi-Harada disease unassociated with clinically evident exudative retinal detachment.

Authors:  Sonia Attia; Sana Khochtali; Rim Kahloun; Dhiaeddine Ammous; Bechir Jelliti; Salim Ben Yahia; Sonia Zaouali; Moncef Khairallah
Journal:  Int Ophthalmol       Date:  2015-05-05       Impact factor: 2.031

2.  Enhanced depth imaging is less suited than indocyanine green angiography for close monitoring of primary stromal choroiditis: a pilot report.

Authors:  Ozlem Balci; Amel Gasc; Bruno Jeannin; Carl P Herbort
Journal:  Int Ophthalmol       Date:  2016-08-02       Impact factor: 2.031

3.  Indocyanine green angiography-guided management of Vogt-Koyanagi-Harada disease: differentiation between choroidal scars and active lesions.

Authors:  Pascal B Knecht; Alessandro Mantovani; Carl P Herbort
Journal:  Int Ophthalmol       Date:  2013-01-01       Impact factor: 2.031

4.  Contribution of dual fluorescein and indocyanine green angiography to the appraisal of posterior involvement in birdshot retinochoroiditis and Vogt-Koyanagi-Harada disease.

Authors:  Ozlem Balci; Bruno Jeannin; Carl P Herbort
Journal:  Int Ophthalmol       Date:  2017-03-15       Impact factor: 2.031

5.  Differences in the clinical features of two types of Vogt-Koyanagi-Harada disease: serous retinal detachment and optic disc swelling.

Authors:  Yoko Okunuki; Kinya Tsubota; Takeshi Kezuka; Hiroshi Goto
Journal:  Jpn J Ophthalmol       Date:  2014-12-03       Impact factor: 2.447

6.  Long-term changes of choroidal blood flow velocity in Vogt-Koyanagi-Harada disease.

Authors:  Shinya Abe; Tomoko Nakamura; Erika Okumura; Toshihiko Oiwake; Annabelle A Okada; Atsushi Hayashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-01-04       Impact factor: 3.117

7.  Initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease presenting with unilateral exudative retinal detachment despite bilateral choroidal involvement.

Authors:  Abdulrahman F AlBloushi; Carl P Herbort; Ahmed M Abu El-Asrar
Journal:  Int Ophthalmol       Date:  2021-08-03       Impact factor: 2.031

8.  Comparison of the Clinical Manifestations between Acute Vogt-Koyanagi-Harada Disease and Acute Bilateral Central Serous Chorioretinopathy.

Authors:  Woo Beom Shin; Min Kyo Kim; Christopher Seungkyu Lee; Sung Chul Lee; Hyesun Kim
Journal:  Korean J Ophthalmol       Date:  2015-11-25

Review 9.  Precise, simplified diagnostic criteria and optimised management of initial-onset Vogt-Koyanagi-Harada disease: an updated review.

Authors:  Carl P Herbort; Ilknur Tugal-Tutkun; Ahmed Abu-El-Asrar; Amod Gupta; Masaru Takeuchi; Christine Fardeau; Alireza Hedayatfar; Cristhian Urzua; Ioannis Papasavvas
Journal:  Eye (Lond)       Date:  2021-06-18       Impact factor: 3.775

10.  Reactivation of Vogt-Koyanagi-Harada disease under control for more than 6 years, following anti-SARS-CoV-2 vaccination.

Authors:  Ioannis Papasavvas; Carl P Herbort
Journal:  J Ophthalmic Inflamm Infect       Date:  2021-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.